AAAAAA
Results:
1-7
|
Results: 7
Authors:
Van Cott, KE
Lubon, H
Gwazdauskas, FC
Knight, J
Drohan, WN
Velander, WH
Citation: Ke. Van Cott et al., Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels, TRANSGEN RE, 10(1), 2001, pp. 43-51
Authors:
Tuthill, DD
Bayer, V
Gallagher, AM
Drohan, WN
MacPhee, MJ
Citation: Dd. Tuthill et al., Assessment of topical hemostats in a renal hemorrhage model in heparinizedrats, J SURG RES, 95(2), 2001, pp. 126-132
Authors:
Maddox, E
Zhan, M
Mundy, GR
Drohan, WN
Burgess, WH
Citation: E. Maddox et al., Optimizing human demineralized bone matrix for clinical application, TISSUE ENG, 6(4), 2000, pp. 441-448
Authors:
Van Cott, KE
Butler, SP
Russell, CG
Subramanian, A
Lubon, H
Gwazdauskas, FC
Knight, J
Drohan, WN
Velander, WH
Citation: Ke. Van Cott et al., Transgenic pigs as bioreactors: a comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland, GENET A-BIO, 15(3-5), 1999, pp. 155-160
Authors:
Drohan, WN
Cervenakova, L
Citation: Wn. Drohan et L. Cervenakova, Safety of blood products: Are transmissible spongiform encephalopathies (prion diseases) a risk?, THROMB HAEM, 82(2), 1999, pp. 486-493
Authors:
Lavoie, TB
Mohan, S
Lipschultz, CA
Grivel, JC
Li, Y
Mainhart, CR
Kam-Morgan, LNW
Drohan, WN
Smith-Gill, SJ
Citation: Tb. Lavoie et al., Structural differences among monoclonal antibodies with distinct fine specificities and kinetic properties, MOL IMMUNOL, 36(17), 1999, pp. 1189-1205
Authors:
Brown, P
Cervenakova, L
McShane, LM
Barber, P
Rubenstein, R
Drohan, WN
Citation: P. Brown et al., Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood componentsdo not transmit Creutzfeldt-Jakob disease in humans, TRANSFUSION, 39(11-12), 1999, pp. 1169-1178
Risultati:
1-7
|